You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

POTASSIUM CITRATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Potassium Citrate, and when can generic versions of Potassium Citrate launch?

Potassium Citrate is a drug marketed by Ut Sw Medctr, Ani Pharms, Ascent Pharms Inc, Bionpharma, Hibrow Hlthcare, Rising, Strides Pharma, Teva Pharms Usa Inc, Torrent, and Zydus Pharms. and is included in ten NDAs.

The generic ingredient in POTASSIUM CITRATE is potassium citrate. There are two hundred and forty drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the potassium citrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Potassium Citrate

A generic version of POTASSIUM CITRATE was approved as potassium citrate by RISING on June 9th, 2006.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for POTASSIUM CITRATE?
  • What are the global sales for POTASSIUM CITRATE?
  • What is Average Wholesale Price for POTASSIUM CITRATE?
Summary for POTASSIUM CITRATE
Drug patent expirations by year for POTASSIUM CITRATE
Drug Prices for POTASSIUM CITRATE

See drug prices for POTASSIUM CITRATE

Recent Clinical Trials for POTASSIUM CITRATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of UtahPhase 2/Phase 3
Columbia UniversityPhase 2/Phase 3
University of Pittsburgh Medical CenterPhase 2/Phase 3

See all POTASSIUM CITRATE clinical trials

Pharmacology for POTASSIUM CITRATE
Medical Subject Heading (MeSH) Categories for POTASSIUM CITRATE
Anatomical Therapeutic Chemical (ATC) Classes for POTASSIUM CITRATE

US Patents and Regulatory Information for POTASSIUM CITRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ut Sw Medctr POTASSIUM CITRATE potassium citrate FOR SOLUTION;ORAL 019647-002 Oct 13, 1988 DISCN Yes No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Teva Pharms Usa Inc POTASSIUM CITRATE potassium citrate TABLET, EXTENDED RELEASE;ORAL 209758-001 Mar 5, 2018 AB RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Zydus Pharms POTASSIUM CITRATE potassium citrate TABLET, EXTENDED RELEASE;ORAL 203546-001 Aug 6, 2014 AB RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Ascent Pharms Inc POTASSIUM CITRATE potassium citrate TABLET, EXTENDED RELEASE;ORAL 214420-003 Feb 5, 2021 AB RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Ani Pharms POTASSIUM CITRATE potassium citrate TABLET, EXTENDED RELEASE;ORAL 212779-002 Jan 14, 2020 AB RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

POTASSIUM CITRATE Market Analysis and Financial Projection Experimental

Potassium Citrate Market Dynamics and Financial Trajectory

Market Overview

The potassium citrate market is poised for significant growth, driven by various factors across different industries. Here are the key dynamics and financial projections for this market.

Market Size and Growth Projections

  • The global potassium citrate market is expected to expand substantially over the next few years. By 2023, the market was valued at approximately USD 705.23 million and is projected to reach USD 947.77 million by 2033, growing at a CAGR of 3%[1].
  • Another projection indicates that the market could reach a valuation of USD 8.89 billion by 2024 and grow to USD 23.68 billion by 2033, with a CAGR of 11.5%[2].
  • A more conservative estimate suggests the market will grow at a CAGR of 3.05%, reaching USD 746.804 million by 2029 from USD 605.110 million in 2022[4].

Geographic Distribution

  • The Asia-Pacific region dominates the global potassium citrate market, with China being the largest producer and exporter. China's exports to the United States are particularly significant due to the competitive pricing and high demand[1][4].
  • The region's rapid industrialization and the growth of the food, pharmaceutical, and cosmetic industries are key drivers of this market[4].

End-Use Industries

  • The demand for potassium citrate is highest in the food and beverage industry, where it is used as a buffering agent, stabilizer, flavoring agent, and anti-oxidation agent[3].
  • The pharmaceutical industry is another major consumer, with potassium citrate used to treat conditions such as kidney stones and urinary tract infections (UTIs)[4].
  • The personal care and cosmetics sector also contributes significantly to the market growth, driven by the increasing demand for clean label and natural ingredients[3].

Market Drivers

  • Growing awareness about the benefits of low sodium levels in food has led to an increased demand for potassium citrate as a substitute for sodium citrate[1].
  • The expansion of the processed food industry is another significant driver, as potassium citrate is widely used in food processing[1].
  • Increasing consumption of functional foods and beverages, along with the expanding applications in the pharmaceutical industry, are expected to create growth opportunities[3].

Key Players

  • Major players in the potassium citrate market include Cargill, Incorporated, Jungbunzlauer Suisse AG, Gadot Biochemical Industries Ltd, Foodchem International Corporation, and Merck KGaA[3].

Financial Trends in Healthcare

  • In the healthcare sector, particularly for treating kidney stones, the cost of potassium citrate has been a significant factor. From 2013 to 2020, spending on potassium citrate nearly doubled, from approximately $13.7 million to $27.2 million. However, there has been a decrease in the cost from 2018 to 2022 due to increased awareness and the availability of cheaper alternatives[5].
  • Studies suggest that switching to more affordable alternatives could save between $11.6 million and $23.6 million annually, highlighting the need for cost-effective treatments to improve patient compliance[5].

Market Segmentation

  • The market is segmented based on grade (industrial, food, pharmaceuticals) and end-user applications (food and beverage, industrial, pharmaceuticals, cosmetics)[4].
  • Regional segmentation includes North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, Japan, and Middle East & Africa[1].

Consumer Preferences and Industry Dynamics

  • Evolving consumer preferences for natural and clean label ingredients are driving the demand for potassium citrate in various industries[3].
  • The need for electrolyte balance and overall health promotion is also a significant factor, reflecting in the increased consumption of potassium citrate in health-related products[3].

Key Takeaways

  • The potassium citrate market is expected to grow significantly over the next decade, driven by increasing demand from the food, pharmaceutical, and personal care industries.
  • Asia-Pacific, particularly China, dominates the market due to high production and export volumes.
  • The market is segmented based on grade and end-use applications, with key players like Cargill and Jungbunzlauer Suisse AG leading the market.
  • Financial trends indicate a potential for cost savings by switching to more affordable alternatives in healthcare.

FAQs

1. What is the projected market size of the potassium citrate market by 2033? The market is projected to reach USD 947.77 million by 2033, growing at a CAGR of 3% from 2023[1].

2. Which region dominates the global potassium citrate market? The Asia-Pacific region, particularly China, dominates the global potassium citrate market due to high production and export volumes[1][4].

3. What are the primary end-use industries for potassium citrate? The primary end-use industries are the food and beverage, pharmaceutical, and personal care and cosmetics sectors[3][4].

4. What are the key drivers of the potassium citrate market growth? Key drivers include growing awareness about low sodium levels in food, expansion of the processed food industry, and increasing demand for clean label and natural ingredients[1][3].

5. How has the cost of potassium citrate in healthcare changed over recent years? The cost of potassium citrate in healthcare has seen a decrease from 2018 to 2022 due to increased awareness and the availability of cheaper alternatives, although overall spending nearly doubled from 2013 to 2020[5].

Sources

  1. Future Market Insights, "Potassium Citrate Market Size, Share & Trends – 2033 | FMI"
  2. Reports and Data, "Potassium Citrate Market 2024 - Reports and Data"
  3. IndustryARC, "Potassium Citrate Market Size Report, 2021-2026 - IndustryARC"
  4. Knowledge Sourcing, "Potassium Citrate Market Size & Share: Industry Report, 2024-2029"
  5. UroToday, "AUA 2024: Trends in Usage and Cost of Potassium Citrate and Alternative Alkalizing Agents for Nephrolithiasis"

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.